68 related articles for article (PubMed ID: 11766082)
41. [Steroid receptors and breast carcinoma].
Pasić R; Dulbegović B; Softić D; Wittlif JL
Med Pregl; 1991; 44(1-2):48-51. PubMed ID: 1870463
[TBL] [Abstract][Full Text] [Related]
42. [Differences and clinical significance of receptor expression between primary and locally recurrent breast tumor tissues].
Ma XM; Han YW; Zhang J; Cui WJ; Wang X
Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):372-6. PubMed ID: 24054015
[TBL] [Abstract][Full Text] [Related]
43. Combined microRNA and ER expression: a new classifier for familial and sporadic breast cancer patients.
Danza K; De Summa S; Pilato B; Carella M; Palumbo O; Popescu O; Paradiso A; Pinto R; Tommasi S
J Transl Med; 2014 Nov; 12():319. PubMed ID: 25406994
[TBL] [Abstract][Full Text] [Related]
44. Glucosiduronidation of androsterone by human breast tumors in vitro in relation to the progesterone receptor content.
Raju U; Levitz M; Kaganowicz A; Blaustein A
Steroids; 1983 Oct; 42(4):449-55. PubMed ID: 6437021
[TBL] [Abstract][Full Text] [Related]
45. Male Breast Cancer: An Updated Review of Patient Characteristics, Genetics, and Outcome.
Khare VS; Huda F; Misra S; Amulya KR; Raj N; Karn S; Basu S
Int J Breast Cancer; 2024; 2024():9003572. PubMed ID: 38559438
[TBL] [Abstract][Full Text] [Related]
46. Relationship between family history of breast cancer and clinicopathological features in Moroccan patients.
Tazzite A; Jouhadi H; Saiss K; Benider A; Nadifi S
Ethiop J Health Sci; 2013 Jul; 23(2):150-7. PubMed ID: 23950631
[TBL] [Abstract][Full Text] [Related]
47. Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy.
Cui X; Schiff R; Arpino G; Osborne CK; Lee AV
J Clin Oncol; 2005 Oct; 23(30):7721-35. PubMed ID: 16234531
[TBL] [Abstract][Full Text] [Related]
48. Familial and sporadic breast cancers: differences in clinical, histopathological, and immunohistochemical features.
D'Eredita' G; Giardina C; Napoli A; Troilo VL; Fischetti F; Berardi T
Int J Surg Pathol; 2011 Dec; 19(6):724-32. PubMed ID: 20308044
[TBL] [Abstract][Full Text] [Related]
49. Ratio of concentrations of estrogen receptors to progesterone receptors (ER/PR) in the cytosol of breast cancers (stratification by forming of groups differing in PR).
Hochmann J
Neoplasma; 2007; 54(4):290-6. PubMed ID: 17822318
[TBL] [Abstract][Full Text] [Related]
50. BRCA1 protein expression and its correlation with ER/PR status in sporadic and familial breast cancer in Eastern Indian patients--a hospital based study.
Ashraf M; Jha JK; Mukherjee N; Panda CK; Nayak S; Jadhav TS; Dikshit N; Nath NC; Chakraborty J; Biswas J
J Indian Med Assoc; 2011 Dec; 109(12):873-8. PubMed ID: 23469566
[TBL] [Abstract][Full Text] [Related]
51. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
Bae SY; Kim S; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Lee JE; Nam SJ
BMC Cancer; 2015 Mar; 15():138. PubMed ID: 25880075
[TBL] [Abstract][Full Text] [Related]
52. Estrogen and progesterone receptors in breast cancer.
Yip CH; Rhodes A
Future Oncol; 2014 Nov; 10(14):2293-301. PubMed ID: 25471040
[TBL] [Abstract][Full Text] [Related]
53. Differences in the progesterone receptor contents between familial breast cancers and sporadic breast cancers stratified by patient age.
Fukutomi T; Akashi-Tanaka S
Surg Today; 2001; 31(11):963-7. PubMed ID: 11766082
[TBL] [Abstract][Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
